RESUMEN
AIM: Products for on-site urine drug testing offer the possibility to perform screening for drugs of abuse directly at the point-of-care. This is a well-established routine in emergency and dependency clinics but further evaluation of performance is needed due to inherent limitations with the available products. METHODS: Urine drug testing by an on-site product was compared with routine laboratory methods. First, on-site testing was performed at the laboratory in addition to the routine method. Second, the on-site testing was performed at a dependency clinic and urine samples were subsequently sent to the laboratory for additional analytical investigation. RESULTS: The on-site testing products did not perform with assigned cut-off levels. The subjective reading between the presence of a spot (i.e. negative test result) being present or no spot (positive result) was difficult in 3.2% of the cases, and occurred for all parameters. The tests performed more accurately in drug negative samples (specificity 96%) but less accurately for detecting positives (sensitivity 79%). Of all incorrect results by the on-site test the proportion of false negatives was 42%. The overall agreement between on-site and laboratory testing was 95% in the laboratory study and 98% in the clinical study. CONCLUSION: Although a high degree of agreement was observed between on-site and routine laboratory urine drug testing, the performance of on-site testing was not acceptable due to significant number of false negative results. The limited sensitivity of on-site testing compared to laboratory testing reduces the applicability of these tests.
Asunto(s)
Detección de Abuso de Sustancias/métodos , Anfetaminas/orina , Analgésicos Opioides/orina , Benzodiazepinas/orina , Buprenorfina/orina , Cannabinoides/orina , Estudios de Evaluación como Asunto , Reacciones Falso Negativas , Humanos , Metadona/orina , Sensibilidad y Especificidad , Detección de Abuso de Sustancias/normas , Tramadol/orinaRESUMEN
AIM: The study aimed to collect information concerning the increasing use of new psychoactive substances, commonly sold through online shops as 'Internet drugs' or 'legal highs', or in terms of masked products such as 'bath salts' and 'plant food'. METHODS: The Karolinska Institutet and Karolinska University Laboratory and the Swedish Poisons Information Centre have initiated a project called 'STRIDA' aiming to monitor the occurrence and trends of new psychoactive substances in Sweden, and collect information about their clinical symptoms, toxicity and associated health risks. A liquid chromatographic-tandem mass spectrometric (LC-MS/MS) multi-component method has been developed, currently allowing for the determination of > 80 novel psychoactive compounds or metabolites thereof. This study focused mainly on the particular drug substances identified and the population demographics of the initial STRIDA cases. RESULTS: In urine and/or blood samples obtained from 103 consecutive cases of admitted or suspected recreational drug intoxications in mostly young subjects (78% were ≤ 25 years, and 81% were males) presenting at emergency departments all over the country, psychoactive substances were detected in 82%. The substances comprised synthetic cannabinoids ('Spice'; JWH analogues), substituted cathinones ('bath salts'; e.g. butylone, MDPV and methylone) and tryptamines (4-HO-MET), plant-based substances (mitragynine and psilocin), as well as conventional drugs-of-abuse. In 44% of the cases, more than one new psychoactive substance, or a mixture of new and/or conventional drugs were detected. CONCLUSION: The initial results of the STRIDA project have documented use of a broad variety of new psychoactive substances among mainly young people all over Sweden.
Asunto(s)
Drogas Ilícitas/sangre , Psicotrópicos/sangre , Trastornos Relacionados con Sustancias/epidemiología , Adolescente , Adulto , Anfetaminas/sangre , Benzodiazepinas/sangre , Agonistas de Receptores de Cannabinoides/sangre , Femenino , Humanos , Indoles/sangre , Masculino , Metanfetamina/análogos & derivados , Metanfetamina/sangre , Persona de Mediana Edad , Psilocibina/análogos & derivados , Psilocibina/sangre , Alcaloides de Triptamina Secologanina/sangre , Trastornos Relacionados con Sustancias/sangre , Suecia/epidemiología , Triptaminas/sangre , Adulto JovenAsunto(s)
Benzodioxoles/envenenamiento , Drogas de Diseño/envenenamiento , Psicotrópicos/envenenamiento , Pirrolidinas/envenenamiento , Benzodioxoles/análisis , Benzodioxoles/química , Estimulantes del Sistema Nervioso Central/análisis , Estimulantes del Sistema Nervioso Central/química , Estimulantes del Sistema Nervioso Central/envenenamiento , Cromatografía Liquida , Drogas de Diseño/análisis , Drogas de Diseño/química , Servicios Médicos de Urgencia/estadística & datos numéricos , Humanos , Drogas Ilícitas/análisis , Drogas Ilícitas/química , Drogas Ilícitas/envenenamiento , Internet , Registros Médicos , Admisión del Paciente/estadística & datos numéricos , Fenetilaminas/química , Intoxicación/diagnóstico , Intoxicación/terapia , Psicotrópicos/análisis , Psicotrópicos/química , Pirrolidinas/análisis , Pirrolidinas/química , Estudios Retrospectivos , Medición de Riesgo , Suecia , Espectrometría de Masas en Tándem , Cathinona SintéticaAsunto(s)
Drogas Ilícitas , Internet , Centros de Control de Intoxicaciones , Psicotrópicos , Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Toxicología Forense , Cromatografía de Gases y Espectrometría de Masas , Alucinógenos/análisis , Alucinógenos/toxicidad , Humanos , Drogas Ilícitas/análisis , Drogas Ilícitas/toxicidad , Psicotrópicos/análisis , Psicotrópicos/toxicidad , Medición de Riesgo , Suecia , Espectrometría de Masas en TándemRESUMEN
The "STRIDA" project monitors the occurrence and trends of new psychoactive substances (NPS; "Internet drugs/designer drugs/legal highs") in Sweden, and collects information about their clinical symptoms, toxicity and associated health hazards. The initial results of the project documented a widespread use of many different NPS by mainly adolescents and young (age range 13-63 years, median 20), male (79%) adults, among cases of drug intoxications presenting at emergency departments and intensive care units across the country. The new substances were identified in samples of urine and blood by a multi-component LC-MS/MS method, and the severity of clinical symptoms were graded by the Poisoning Severity Score (PSS). Of the initial 189 samples submitted for laboratory investigation, 156 (83%) tested positive for at least one drug. Besides classical substances such as ethanol, cannabis and amphetamines, many NPS were detected comprising synthetic cannabinoid receptor agonists ("Spice"), piperazines, substituted phenethylamines, synthetic cathinones, hallucinogenic tryptamines, piperidines, opioid related substances, ketamine and related substances, and GABA analogues (in total more than 50 substances). About half of the cases were demonstrated to be multiple drug intoxications, sometimes making it hard to associate the clinical presentations with one specific substance. In conclusion, the STRIDA project has documented use of a broad variety of NPS among mainly young people all over Sweden.
Asunto(s)
Drogas de Diseño/análisis , Psicotrópicos/sangre , Psicotrópicos/orina , Trastornos Relacionados con Sustancias/epidemiología , Adolescente , Adulto , Depresores del Sistema Nervioso Central/sangre , Depresores del Sistema Nervioso Central/orina , Drogas de Diseño/química , Servicio de Urgencia en Hospital , Etanol/sangre , Etanol/orina , Femenino , Toxicología Forense , Humanos , Masculino , Persona de Mediana Edad , Narcóticos/sangre , Narcóticos/orina , Psicotrópicos/química , Suecia/epidemiología , Adulto JovenAsunto(s)
Antitusígenos/envenenamiento , Alucinógenos/envenenamiento , Piperazinas/envenenamiento , Adolescente , Adulto , Dextrometorfano/envenenamiento , Sobredosis de Droga , Humanos , Psicosis Inducidas por Sustancias/diagnóstico , Psicosis Inducidas por Sustancias/etiología , Factores de Riesgo , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/diagnóstico , Trastornos Relacionados con Sustancias/psicologíaAsunto(s)
Guías de Práctica Clínica como Asunto , Mordeduras de Serpientes/terapia , Animales , Antivenenos/uso terapéutico , Traumatismos de la Mano/patología , Traumatismos de la Mano/terapia , Humanos , Mordeduras de Serpientes/patología , Venenos de Víboras/antagonistas & inhibidores , ViperidaeRESUMEN
Preparations of the plant Acorus calamus (calamus or sweet flag) (A. calamus) are available via internet trade and marketed as being hallucinogenic. In 2003-2006, the Swedish Poisons Information Centre received inquiries about 30 clinical cases of intentional intoxication with A. calamus products. The present investigation aimed to identify alpha- and beta-asarone, considered active components of A. calamus, and metabolites thereof in urine samples collected in seven of these cases. To further aid the identification of asarone biotransformation products, a calamus oil preparation was incubated with the fungus Cunninghamella elegans, which is used as a microbial model of mammalian drug metabolism. Using gas chromatography-mass spectrometry (GC-MS) analysis in selected ion monitoring mode, alpha-asarone was detected in five urine samples at concentrations ranging between approximately 11 and 1150 microg/L and beta-asarone in four of those at approximately 22-220 microg/L. A previously identified asarone metabolite, trans-2,4,5-trimethoxycinnamic acid (trans-TMC), was detected in the fungus broth by liquid chromatography-tandem mass spectrometry whereas cis-TMC was tentatively identified in the human urine samples. Using GC-MS, a hydroxylated asarone metabolite was identified both in fungus broth and urine samples. However, this study demonstrated no evidence for the presence of 2,4,5-trimethoxyamphetamine, claimed as a hallucinogenic component of A. calamus. The main clinical symptom reported by the patients was prolonged vomiting that sometimes lasted more than 15 h.
Asunto(s)
Acorus , Anisoles/toxicidad , Alucinógenos/toxicidad , Aceites de Plantas/toxicidad , Adolescente , Adulto , Derivados de Alilbenceno , Anfetaminas/orina , Anisoles/orina , Biotransformación , Cromatografía Liquida , Cinamatos/orina , Cunninghamella/metabolismo , Remoción de Radical Alquila , Femenino , Cromatografía de Gases y Espectrometría de Masas , Alucinógenos/orina , Humanos , Hidroxilación , Masculino , Aceites de Plantas/metabolismo , Intoxicación/orina , Espectrometría de Masas en Tándem , Vómitos/inducido químicamente , Vómitos/orina , Adulto JovenRESUMEN
INTRODUCTION: Problems associated with the increasing abuse of plant-derived psychoactive substances have recently attracted attention. This study involved bioanalytical and clinical examinations of intoxication cases suspected to be linked to such plant materials. METHODS: Urine samples were collected at emergency wards in Sweden from patients who either admitted or were suspected of ingestion of psychoactive plant materials. The bioanalytical investigation employed a liquid chromatography-tandem mass spectrometry multicomponent method covering 10 plant-derived substances (atropine, dimethyltryptamine, ephedrine, harmaline, harmine, ibogaine, lysergic acid amide, psilocin, scopolamine, and yohimbine) and a gas chromatography-mass spectrometry method for asarone. Routine testing for illicit drugs was also performed. RESULTS: Over a 4-year period, 103 urine samples collected from mainly young people (age range 13-52 years, median 19) were studied. Among 53 cases where ingestion of any of the 11 plant-derived substances covered in this study was admitted or suspected, 41 (77%) could be confirmed bioanalytically. Nine of the 11 substances tested for were detected, the exceptions being ibogaine and yohimbine. Psilocin, originating from ingestion of hallucinogenic mushrooms, was the most frequent drug accounting for 54% of the cases. The most common means of drug acquisition (56%) was purchase over the Internet. CONCLUSION: The patients using psychoactive plant materials were mainly young and commonly used the Internet for drug acquisition. Having access to bioanalytical methods for detection of plant-derived psychoactives is therefore considered important, when providing clinical toxicology service.
Asunto(s)
Extractos Vegetales/envenenamiento , Plantas Tóxicas/envenenamiento , Intoxicación/etiología , Psicotrópicos/envenenamiento , Adolescente , Adulto , Cromatografía Líquida de Alta Presión , Servicio de Urgencia en Hospital , Femenino , Alucinógenos/envenenamiento , Alucinógenos/orina , Humanos , Masculino , Persona de Mediana Edad , Extractos Vegetales/orina , Plantas Tóxicas/química , Intoxicación/orina , Psicotrópicos/orina , Espectrometría de Masa por Ionización de Electrospray , Espectrometría de Masas en Tándem , Adulto JovenRESUMEN
INTRODUCTION: Dermal exposure to hydrofluoric acid (HF) may cause severe burns and systemic toxicity. Hexafluorine (Prevor, France) is a product marketed as an emergency decontamination fluid for HF skin and eye exposures. Documentation concerning Hexafluorine is scanty, and a recent study indicates that its ability to reduce HF burns is at most equal to that of water. OBJECTIVE: The present study was conducted to evaluate Hexafluorine's capacity to reduce HF-induced systemic toxicity. METHODS: Sprague Dawley rats were anesthetized, catheterized in the left femoral artery, and shaved on their back. A filter paper (3.5 x 6 cm) was soaked in 50% HF and applied on the back of each rat for 3 min. Thirty seconds after removal of the paper, a 3-min rinsing with either 500 mL Hexafluorine (group H), 500 mL water (group W), or 500 mL water followed by a single application of 2.5% calcium gluconate gel (group Ca) was carried out. Blood samples were analyzed for ionized calcium and potassium (before injury and 1, 2, 3, and 4 h after) and also for ionized fluoride (1, 2, and 4 h after injury). RESULTS: The animals developed hypocalcemia, hyperkalemia, and hyperfluoridemia after the HF exposure. The only significant difference observed among the groups was in serum potassium at 1 h between group Ca and group W. However, there was a constant trend toward milder hypocalcemia and less pronounced hyperkalemia in group Ca compared to the other groups. There were no differences in the electrolyte disturbances between the Hexafluorine-treated animals and those treated with water only. Five of 39 animals died before completion of the experiment as a result of the HF exposure, one from group Ca and two from each of the other two groups. CONCLUSION: In this experimental study, decontamination with Hexafluorine was not more effective than water rinsing in reducing electrolyte disturbances caused by dermal exposure to hydrofluoric acid.